Next level of immunosuppression: Drug/im
β
Josh Levitsky
π
Article
π
2011
π
John Wiley and Sons
π
English
β 102 KB
## Key Points 1. Current immunological monitoring relies heavily on clinical judgment and therapeutic drug levels and does not adequately assess the functional or donorspecific immunosuppression (IS) status of recipients of liver transplantation (LT). 2. Trough levels of drugs are arbitrary and ar